Results 71 to 80 of about 4,992,809 (126)

Acute Myeloid Leukemia With Florid Plasmacytoid Dendritic Cell Expansion and Aberrant Expression of CD19

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 919-920, October 2026.
Afshin Shameli, Russell K. Dorer
wiley   +1 more source

Accelerating Pediatric Oncology Drug Development: Advances in Clinical Pharmacology, Trial Design, Non‐Clinical Evidence, and Regulatory Science

The Journal of Clinical Pharmacology, Volume 66, Issue 7, July 2026.
Abstract Pediatric oncology drug development remains uniquely challenging due to the rarity and biological heterogeneity of childhood cancers, ethical considerations in trial conduct, and the limited feasibility of large, randomized studies. Despite these barriers, recent years have seen a notable acceleration in the approval of oncology therapies for ...
Ya‐Feng Wen, Xiaoning Wang, Sarandeep Boyanapalli, Lee Anderson, Thao Dang, Guan Xing, Marianna Calvet, Tiffany Hart, Sreeneeranj Kasichayanula, Xiaochen Zhao   +9 more
wiley   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches [PDF]

, 2016
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course and high frequency of cutaneous and bone marrow involvement ...
GRAMMATICO, SARA, Alessandro Pulsoni, Valentini, Caterina Giovanna, Sara Grammatico, Valentini, Caterina G, PULSONI, Alessandro, Livio Pagano, Caterina G. Valentini, Pagano, Livio   +8 more
core   +1 more source

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm

, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incidence is unknown due to lack of diagnostic criteria. Typically, it involves skin and bone marrow and less likely, lymph nodes and visceral organs.
Taylor, Katrina, Bhat, Alina, Mohammadi, Oranus   +2 more
core   +1 more source

Anti‐BCMA immunotherapies deplete plasmacytoid dendritic cells and impair antiviral immunity in multiple myeloma

HemaSphere, Volume 10, Issue 8, August 2026.
Ondrej Venglar, Eva Radova, Maxima Warmuzova, Daniel Bilek, Marketa Kudelkova, Katerina Jasinkova, Ludmila Muronova, Lucie Broskevicova, Veronika Kapustova, Jan Vrana, Tereza Novakova, Katerina Karasova, Michaela Hornakova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michal Simicek, Jakub Radocha, Tereza Sevcikova, David Zihala, Juli Bago, Roman Hajek, Tomas Jelinek   +22 more
wiley   +1 more source

CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm

, 2022
SIMPLE SUMMARY: Until recently, there were no approved therapies for the aggressive blood cancer blastic plasmacytoid dendritic cell neoplasm (BPDCN). Survival for patients diagnosed with BPDCN is under two years, and improved treatments are needed.
Naveen Pemmaraju, Caël, Blandine, Daguindau, Etienne, Lane, Andrew A., Blandine Caël, Etienne Daguindau, Pemmaraju, Naveen, Elodie Bôle-Richard, Bôle-Richard, Elodie, Andrew A. Lane   +9 more
core   +1 more source

Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation

eJHaem
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee, Shawn P. Griffin, Deepa Jeyakumar, Ashley Gamayo, Sherif A. Rezk, Kiran Naqvi   +5 more
doaj   +1 more source

Leucemia aguda de células dendríticas linfoplasmocitóides: relato de caso e revisão da literatura. [PDF]

, 2006
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Sella, Luiz Fernando
core  

Blastic plasmacytoid dendritic cell neoplasm in an elderly woman

, 2013
Blastic plasmacytoid dendritic cell neoplasm (a.k.a. NK cell lymphoma, CD4+CD56+ haematodermic neoplasm) is a rare aggressive tumour that arises from plasmacytoid dendritic cell precursors.
Fazril Zayadi
core  

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source